Dai Maruyama, MD, PhD¹, Kensei Tobinai, MD, PhD², Kiyoshi Ando, MD, PhD³, Ken Ohmachi, MD^3*, Michinori Ogura, MD, PhD⁴, Toshiki Uchida, MD, PhD^4*, Tadashi Nakanishi^5* and Masayuki Namiki, PhD^6*

¹Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
²National Cancer Center Hospital, Tokyo, Japan
³Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
⁴Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
⁵Department of Clinical Development, Eisai Co., Ltd., Tokyo, Japan
⁶Department of Clinical Pharmacology, Eisai Co., Ltd., Tokyo, Japan

Pier Luigi Zinzani, MD, PhD¹, Letizia Gandolfi^2*, Beatrice Casadei^2*, Cinzia Pellegrini^2*, Alessandro Broccoli, MD^2*, Enrico Derenzini, MD^3*, Federica Quirini^2*, Lorenzo Tonialini^2*, Michele Cavo, MD^2*, Lisa Argnani^2* and Vittorio Stefoni^2*

¹Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
²Institute of Hematology, University of Bologna, Bologna, Italy
³DIMES, Department of Hematology and Medical Sciences “L. and A. Seràgnoli”, University of Bologna, Bologna, Italy

Nancy L. Bartlett¹, Andy I Chen, MD, PhD², Kathryn S. Kolibaba^3,4, Thierry Lamy, MD PhD⁵, Surai Jones^6*, Jamie Hirata⁶ and Jeff P. Sharman, MD^4,7

¹Washington University School of Medicine, Siteman Cancer Center, Saint Louis, MO
²Oregon Health & Science University, Portland, OR
³Compass Oncology, Vancouver, WA
⁴US Oncology Research, The Woodlands, TX
⁵INSERM U917 - CHU de Rennes, Rennes, France
⁶Genentech, Inc., South San Francisco, CA
⁷Willamette Valley Cancer Institute, Springfield, OR

Mathias Witzens-Harig, MD^1*, Ulrich Keller^2*, Andreas Viardot, MD^3*, Christian Buske, MD⁴, Anne Crombé^5*, Elisabeth Hoenig^5*, Julia Meissner, MD^6*, Anthony D Ho, MD⁶, Reinhard Marks⁷, Martin H. Dreyling, MD, PhD⁸ and Georg Hess, MD^9*

¹Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany
²III. Department of Internal Medicine, Hematology and Medical Oncology, Technische Universität München, Munich, Germany
³University Hospital of Ulm, Ulm, Germany
⁴Institute of Experimental Tumor Research and Department of Internal Medicine III, University of Ulm, Ulm, Germany
⁵Interdisciplinary Center for Clinical Trials (IZKS), University of Mainz Hospital, Mainz, Germany
⁶Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany
⁷Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany
⁸Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany
⁹Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany

Andrew J. Cowan, MD¹, Philip Stevenson, M.S.^2*, Ted A. Gooley, PhD^2*, Shani L. Frayo^2*, George R. Oliveira, MD^3*, Stephen D. Smith, MD^1,4, Damian J. Green, MD^2,5, Jennifer E. Roden^6*, John M. Pagel, MD, PhD^7*, Brent L Wood, MD, PhD^4,8, Oliver W Press, MD, PhD^1,4 and Ajay K. Gopal, MD^5,9

¹Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Department of Radiology, Harvard Medical School, MGH Hospital, Boston, MA
⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Division of Medical Oncology, University of Washington, Department of Medicine, Seattle, WA
⁶Department of Medicine, University of Washington, Seattle, WA
⁷Swedish Medical Center, Seattle, WA
⁸Department of Laboratory Medicine, University of Washington, Seattle, WA
⁹Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA

Dennis A. Eichenauer, MD^1*, Helen Goergen^2*, Annette Pluetschow^2*, Karolin Behringer, MD^3*, Stefanie Kreissl, MD^2*, Paul Bröckelmann, MD^2*, Michael Fuchs, MD^2*, Boris Böll, MD^2*, Bastian von Tresckow, MD^3*, Peter Borchmann, MD^2,3 and Andreas Engert, MD³

¹German Hodgkin Study Group (GHSG) and Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
²German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany
³Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany

John M. Rossi, MS^1*, Sattva S. Neelapu, MD², William Y. Go, MD, PhD¹, Yueh-wei Shen, MS^1*, Marika Sherman, MS^1*, Frederick L. Locke, MD³, Nancy L Bartlett, MD⁴, Tanya Siddiqi, MD⁵, Lynn Navale, MS^1*, Meg Elias, RN, BSN^1*, Jeff Wiezorek, MD, MS^1* and Adrian Bot, MD, PhD^1*

¹Kite Pharma, Santa Monica, CA
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
⁴Washington University School of Medicine, Saint Louis, MO
⁵Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Tanya Siddiqi, MD¹, Anna Scuto, PhD², Jan H. Beumer, PharmD, PhD^3*, Joo Y. Song, MD⁴, Paul Frankel, PhD^5*, Chris Ruel, MS^5*, Jacob Cobb, BS^6*, Brian F. Kiesel, BS^7*, Dennis D. Weisenburger, MD⁴, Kevin R. Kelly, MD, PhD⁸, Joseph Tuscano, MD⁹, Leslie Popplewell, MD¹⁰, Stephen J. Forman, MD¹¹, Richard Piekarz, PhD, MD^12* and Edward M. Newman, PhD^13*

¹City of Hope National Medical Center, Duarte, CA
²Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA
³Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA
⁴Department of Pathology, City of Hope National Medical Center, Duarte, CA
⁵Biostatistics, City of Hope National Medical Center, Duarte, CA
⁶Pathology, City of Hope National Medical Center, Duarte, CA
⁷Cancer Therapeutics Program, Univerisy of Pittsburgh Cancer Institute, Pittsburgh, PA
⁸University of Southern California Keck School of Medicine, Los Angeles, CA
⁹University of California Davis, Sacramento, CA
¹⁰Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematology and HCT, City of Hope, Duarte, CA
¹²Cancer Therapeutics Evaluation Program, National Cancer Institute, Bethesda, MD
¹³City of Hope, Duarte, CA

Sanghoon Lee, Ph.D, MSc.¹, Changhong Yin, MD, MS^1*, Janet Ayello, MS^1*, Erin Morris, RN^1*, Carmella van de Ven, MA^1* and Mitchell S. Cairo, MD^1,2,3,4,5

¹Pediatrics, New York Medical College, Valhalla, NY
²Cell Biology & Anatomy, New York Medical College, Valhalla, NY
³Microbiology & Immunology, New York Medical College, Valhalla, NY
⁴Pathology, New York Medical College, Valhalla, NY
⁵Medicine, New York Medical College, Valhalla, NY

Pengpeng Xu^1,2*, Huijuan Zhong^1,2* and Weili Zhao, M.D/Ph.D^1,2

¹State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Laboratory of Molecular Pathology, Shanghai, China

Joerg Thomas Bittenbring, MD,^*, Michael Pfreundschuh, MD, Fabian Acker^* and Frank Neumann, PhD^*

Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany

Annalisa Chiappella¹, Patrizia Pregno, MD^1*, Pier Luigi Zinzani¹, Amalia De Renzo^1*, Andrea Evangelista^2*, Alberto Fabbri^1*, Andres J.M. Ferreri¹, Silvia Franceschetti^1*, Roberto Freilone^1*, Anna Marina Liberati¹, Maurizio Martelli^1*, Domenico Novero, MD^3*, Lorella Orsucci, MD^4*, Delia Rota-Scalabrini^1*, Luigi Rigacci¹, Chiara Rusconi^1*, Giorgina Specchia¹, Vittorio Stefoni^1*, Alessandra Tucci^1*, Francesco Zaja¹ and Umberto Vitolo¹

¹On the behalf of FIL; Hematology, Città della Salute Hospital and University, Torino, Italy
²Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
³Patology Unit, Città della Salute Hospital and University, Torino, Italy
⁴Hematology, Città della Salute Hospital and University, Torino, Italy

Robert Chen¹, Ajay K. Gopal, MD², Scott E. Smith³, Stephen Ansell, MD, PhD⁴, Joseph D. Rosenblatt⁵, Kerry J. Savage, MD MSc⁶, Joseph M. Connors, MD⁶, Andreas Engert⁷, Emily K Larsen^8*, Dirk Huebner⁹, Abraham Fong⁸ and Anas Younes, MD¹⁰

¹City of Hope National Medical Center, Duarte, CA
²University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
³Loyola University Medical Center, Maywood, IL
⁴Mayo Clinic, Rochester, MN
⁵University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
⁶British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
⁷University Hospital of Cologne, Cologne, Germany
⁸Seattle Genetics, Inc., Bothell, WA
⁹Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, MA
¹⁰Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Adam M. Petrich, MD¹, Stefan Klaus Barta, MD, MRCP, MS², Frederick Lansigan, MD³, Trent Wang, MD^4*, Ananta Bhatt, M.D.⁵, Garrett Wasp, MD^6*, Addie Hill, MD^6*, Frank C. Passero Jr., MD^7*, Amrit Kahalon, MD^8*, Roopesh R. Kansara, MD⁹, Mitul Gandhi, MD¹⁰, Graham W. Slack, MD^11*, Tatyana Feldman, MD¹², Andrew M. Evens, DO, MSc¹³ and Kerry J. Savage, MD MSc^14,15

¹Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
²Fox Chase Cancer Center, Philadelphia, PA
³Hematology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
⁴Division of Hematology/Oncology, Temple University, Philadelphia, PA
⁵Division of Hematology/Oncology, Dartmouth-Hitchcock Medical Center, West Lebanon, NH
⁶Dartmouth Hitchcock Medical Center, Lebanon, NH
⁷Division of Hematology/Oncology, Tufts Medical Center, Boston, MA
⁸5Centre for Lymphoid Cancer, Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
⁹Centre for Lymphoid Cancer and Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁰Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
¹¹Centre for Lymphoid Cancer and Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
¹²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹³Tufts Medical Center Cancer Center, Boston, MA
¹⁴Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁵British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada

Dai Chihara, MD, PhD¹, Michelle A. Fanale¹, Mansoor Noorani^1*, Jason R Westin, MD¹, Loretta Nastoupil, MD¹, Fredrick B. Hagemeister, MD¹, Luis E. Fayad, MD¹, Jorge E. Romaguera, MD¹, Felipe Samaniego, MD¹, Francesco Turturro, MD¹, Hun Ju Lee, MD^1*, Sattva S. Neelapu, MD¹, Alma Rodriguez, M.D.^1*, Michael Wang, MD¹, Nathan Fowler, MD¹, Roberto N. Miranda, MD², Chitra M. Hosing, MD³, Yago Nieto, MD, PhD³, Richard Eric Davis, M.D.^1* and Yasuhiro Oki, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Nishitha M Reddy, M.B.B.S.¹, David S Morgan, MD¹, John P Greer², Heidi Chen^3*, Steven I. Park, MD⁴ and Kristy L. Richards, PhD, MD⁵

¹Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
²Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
³Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁵weill cornell medical college, New york

Deborah M. Stephens, DO¹, Alexander N Starodub, MD, PhD^2*, John C Byrd, MD³, Heather Horne^4*, William A Wegener, MD, PhD⁴, David M Goldenberg, ScD, MD⁴ and Beth A Christian, MD³

¹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²Indiana University Health Center for Cancer Care, Goshen, IN
³Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁴Immunomedics, Inc., Morris Plains, NJ

Cara A. Rosenbaum, MD¹, Brandelyn Pitcher, MS^2*, Nancy L Bartlett, MD³, Sonali M. Smith, MD⁴, Jane Jijun Liu, MD^5*, Eric D. Hsi, MD⁶, Sin-Ho Jung, PhD^7*, John P. Leonard, MD⁸ and Bruce D. Cheson, MD⁹

¹University of Chicago Medical Center, Chicago, IL
²Duke University Medical Center, Durham, NC
³Washington University School of Medicine, Saint Louis, MO
⁴University of Chicago, Chicago, IL
⁵Illinois Cancer Care, P.C., Peoria, IL
⁶Clinical Pathology, Cleveland Clinic, Cleveland, OH
⁷Alliance Statistics and Data Center, Duke University, Durham, NC
⁸Department of Medicine, Weill Cornell Medical College, New York, NY
⁹Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC

Nathan Fowler, MD¹, Raisa M. Pinto, MD^2*, Chan Yoon Cheah, MD^3*, Sattva S. Neelapu, MD⁴, Francesco Turturro, MD⁴, Fredrick B. Hagemeister, MD⁵, Jorge E. Romaguera, MD⁵, Michelle A. Fanale⁴, Luis E. Fayad, MD⁵, Sheryl Forbes^1*, Janine Khan^1*, Lei Feng, MS^6*, Felipe Samaniego, MD⁷ and Loretta Nastoupil, MD⁸

¹Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma/Myeloma, University of Texas/MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma/Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX

Ajay K Gopal, MD¹, Andrew John Davies, BM, PhD^2*, Ian W. Flinn, MD, PhD³, Paolo Ghia, MD, PhD⁴, Andre Goy, MD⁵, Gilles A. Salles, MD, PhD⁶, Steve Abella, MD^7*, Betsy Philip^7*, Bess Sorenson^7* and Nina D. Wagner-Johnston, MD⁸

¹Division of Medical Oncology, University of Washington, Seattle, WA
²Cancer Sciences Unit, University of Southampton, Salisbury, United Kingdom
³Hematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN
⁴Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milano, Italy
⁵John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁶Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
⁷Gilead Sciences, Inc., Foster City, CA
⁸Department of Medicine, Washington University School of Medicine, St Louis, MO

Ajay K Gopal, MD¹, Brad S Kahl, MD², Christopher Flowers, MD³, Peter Martin, MD⁴, Brian K Link, MD⁵, Stephen Ansell, MD, PhD⁶, Wei Ye^7*, Brian Koh, MD⁷, Steve Abella, MD^7*, Paul M. Barr, MD⁸, Gilles A. Salles, MD, PhD⁹ and Jonathan W. Friedberg, MD, MMSc⁸

¹Division of Medical Oncology, University of Washington, Seattle, WA
²Washington University, St.Louis, MO
³Winship Cancer Institute of Emory University, Atlanta, GA
⁴Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
⁵Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁶Mayo Clinic, Rochester, MN
⁷Gilead Sciences, Inc., Foster City, CA
⁸University of Rochester, Rochester, NY
⁹Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France

Meletios A. Dimopoulos, MD¹, Judith Trotman, FRACP^2*, Alessandra Tedeschi, MD^3*, Jeffrey V. Matous, MD⁴, David Macdonald, MD, MSc, FRCPC⁵, Constantine Tam, MBBS, MD⁶, Oliver Tournilhac, MD^7*, Shuo Ma, MD, PhD⁸, Albert Oriol, MD PhD^9*, Leonard T. Heffner, MD¹⁰, Chaim Shustik, MD¹¹, Ramón García-Sanz, MD, PhD^12*, Robert F. Cornell¹³, Carlos Fernández de Larrea, MD, PhD^14*, Jorge J. Castillo, MD^15*, Miquel Granell, MD^16*, Marie-Christine Kyrtsonis, MD¹⁷, Veronique Leblond, MD¹⁸, Argiris Symeonidis, MD, PhD¹⁹, Priyanka Singh, MS^20*, Jianling Li, MS^20*, Thorsten Graef, MD, PhD²⁰, Elizabeth Bilotti, MSN^20*, Steven Treon, MD, PhD¹⁵ and Christian Buske, MD^21*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
²Department of Haematology, Concord Hospital, University of Sydney, Concord, Australia
³Division of Hematology, Niguarda Cà Granda Hospital, Milan, Italy
⁴Colorado Blood Cancer Institute, Denver, CO
⁵Division of Hematology, Dalhousie University, Halifax, NS, Canada
⁶Peter MacCallum Cancer Centre & St. Vincent's Hospital, Melbourne, Australia
⁷Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France
⁸Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
⁹Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁰Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹¹Royal Victoria Hospital at McGill University Health Centre, Montreal, Canada
¹²Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
¹³Vanderbilt-Ingram Cancer Center, Nashville, TN
¹⁴Department of Hematology, Amyloidosis and Myeloma Unit, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
¹⁵Dana-Farber Cancer Institute, Boston, MA
¹⁶Department of Hematology, Hospital Sant Pau, Barcelona, Spain
¹⁷Laikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Hematology Section, First Department of Propaedeutic Medicine, Athens, Greece
¹⁸Département d’ Hématologie, Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France
¹⁹Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece
²⁰Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
²¹Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany